Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
sodium-coupled multidrug efflux MATE transporter NorM
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| 1ins | - | - | - | ciprofloxacin | Reslit | Candidate |
| Y294C | - | - | - | chlorhexidine | Reslit | Candidate |
| G184V | - | loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| G184W | - | loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| K185I | - | loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| P189S | - | loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| E190K | - | loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| E190A | - | loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| E124V | - | partial loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| D155V | - | partial loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| G187V | - | loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| G187R | - | loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| C196S | - | partial loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| Y384H | - | partial loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| Y384S | - | partial loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| Y384F | - | partial loss of activity | Vibrio cholerae | norfloxacin | Reslit | Candidate |
| A21T | - | - | Pseudomonas aeruginosa | ciprofloxacin|tobramycin | Reslit | Candidate |
| - | sodium-coupled multidrug efflux MATE transporter NorM promoter region | Neisseria gonorrhoeae | quinolones | Reference Gene Catalog | Candidate | |
| - | - | - | chlorhexidine | Reslit | Candidate | |
| - | sodium-coupled multidrug efflux MATE transporter NorM promoter region | Neisseria gonorrhoeae | quinolones | Reference Gene Catalog | Candidate | |
| - | - | Pseudomonas aeruginosa | ciprofloxacin|tobramycin | Reslit | Candidate |
Cloning and characterization of the Burkholderia vietnamiensis norM gene encoding a multi-drug efflux protein.
The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds.
NorM, an Erwinia amylovora multidrug efflux pump involved in in vitro competition with other epiphytic bacteria.
The study identifies NorM, a multidrug efflux pump in Erwinia amylovora, which confers resistance to several hydrophobic cationic compounds and plays a role in resisting antibiotics produced by epiphytic P. agglomerans.
Analysis of the topology of Vibrio cholerae NorM and identification of amino acid residues involved in norfloxacin resistance.
The study identifies NorM as a multidrug efflux pump in Vibrio cholerae that confers resistance to norfloxacin, ciprofloxacin, and ethidium bromide. Specific amino acid mutations in NorM, such as G184V, G184W, K185I, P189S, E190K, and E190A, significantly reduce or eliminate its resistance function.
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia.
The study identifies several genes and mechanisms involved in extreme antimicrobial peptide and polymyxin B resistance in Burkholderia species, including waaF, ugd BCAL2946, ugd BCAM0855, rpoE, norM, zmpA, zmpB, mucD, and ispH.
Complete genome analysis of a Haemophilus parasuis serovar 12 strain from China.
Three drug-resistant genes were identified in Haemophilus parasuis serovar 12 strain ZJ0906: dfra26 (trimethoprim resistance), pbp1a (penicillin resistance), and norm (ciprofloxacin resistance).
WGS to predict antibiotic MICs for Neisseria gonorrhoeae.
The study identifies various AMR genes and mutations in Neisseria gonorrhoeae that contribute to resistance against multiple antibiotics, including cefixime, penicillin, azithromycin, ciprofloxacin, and tetracycline. These findings are supported by WGS and multivariate linear regression models.
cis- and trans-Acting Factors Influence Expression of the norM-Encoded Efflux Pump of Neisseria gonorrhoeae and Levels of Gonococcal Susceptibility to Substrate Antimicrobials.
The study identifies norM as a gene encoding an efflux pump that contributes to resistance against ciprofloxacin, solithromycin, berberine, and ethidium bromide in Neisseria gonorrhoeae. The expression of norM is regulated by cis- and trans-acting factors, including a poly(T) tract in the promoter and a TetR-like regulator.
Insertion Sequences Mediate Transcriptional Upregulation in B. caccae
The study identifies IS614, a Bacteroides insertion sequence, and other genomic variations in Bacteroides caccae that may contribute to its dominance in the gut microbiome during antibiotic treatment.
Sub-Inhibitory Concentrations of Chlorhexidine Induce Resistance to Chlorhexidine and Decrease Antibiotic Susceptibility in Neisseria gonorrhoeae.
Exposure to sub-lethal chlorhexidine concentrations induced resistance to chlorhexidine and cross-resistance to other antibiotics in Neisseria gonorrhoeae. Mutations in norM, mtrR, and mlaA were associated with increased chlorhexidine resistance.
The Role of Hypermutation and Collateral Sensitivity in Antimicrobial Resistance Diversity of Pseudomonas aeruginosa Populations in Cystic Fibrosis Lung Infection.
The study identifies several genes and mutations associated with antimicrobial resistance in Pseudomonas aeruginosa populations from cystic fibrosis patients, including ampC, mexB, norM, gyrA, and mutations in mutS and mutL.
The role of hypermutation and collateral sensitivity in antimicrobial resistance diversity of Pseudomonas aeruginosa populations in cystic fibrosis lung infection.
The study reveals that hypermutator strains of P. aeruginosa in CF lungs exhibit increased sensitivity to antimicrobials despite their genetic diversity. Key genes like ampC, mexB, mexY, and norM were found to influence resistance profiles, while mutations in mutS and mutL contributed to hypermutation and altered susceptibility.
Global genomic and antimicrobial resistance profiling of Neisseria gonorrhoeae: Insights from whole genome sequencing and minimum inhibitory concentration analysis.
The study identifies key resistance mechanisms in Neisseria gonorrhoeae, including the widespread presence of efflux pump genes (norM, farB, mtrC, mtrA) and specific resistance genes such as bla TEM, tet(C), and erm(C). It highlights the increasing prevalence of antimicrobial resistance and the need for global surveillance and targeted interventions.
A Comprehensive Meta-Analysis on Antimicrobial Resistance Patterns of the Two Major Brucella species in Mediterranean Basin Countries.
The study identifies several AMR genes and mutations in Brucella species, including rpoB mutations conferring rifampicin resistance, gyrA and gyrB mutations linked to ciprofloxacin resistance, and the presence of Brucella_suis_mprF and related bep genes associated with resistance to multiple antibiotics. Additionally, the NorM efflux pump was detected in Brucella melitensis.
Genome analysis of Actinobacillus pleuropneumoniae strain APPFJLYC01 reveals multidrug resistance and high virulence potential.
The study identified 10 antibiotic resistance genes in the Actinobacillus pleuropneumoniae strain APPFJLYC01, including genes conferring resistance to multiple antibiotic classes such as β-lactams, tetracyclines, aminoglycosides, and macrolides.
NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli.
The study identified norM, a gene encoding a putative multidrug efflux protein in Vibrio parahaemolyticus, which confers resistance to multiple antimicrobial agents including norfloxacin, ciprofloxacin, ethidium, kanamycin, and streptomycin. A homologous gene, ydhE, was also identified in Escherichia coli with similar resistance profiles.
NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli.
No comments yet. Be the first to comment!